You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Disease Progression

Showing 9976 - 10000 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

NSCLC Trial (Sutetinib Maleate Capsule)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • Sutetinib Maleate Capsule
  • (no location specified)
Aug 18, 2023

Diabetes, Pre Diabetes, Fatty Liver Trial in Baltimore (Diabetes Prevention Program (DPP), Diabetes Self-Management Training

Not yet recruiting
  • Diabetes
  • +3 more
  • Diabetes Prevention Program (DPP), Diabetes Self-Management Training (DSMT)
  • Baltimore, Maryland
    University of Maryland Center for Diabetes and Endocrinology
Mar 2, 2023

Sarcoma Trial in Worldwide (RG1507)

Terminated
Has Results
  • Sarcoma
  • Duarte, California
  • +40 more
Jan 14, 2021

Adult Alveolar Soft Part Sarcoma, Adult Angiosarcoma, Adult Desmoplastic Small Round Cell Tumor Trial in Portland, Seattle

Completed
Has Results
  • Adult Alveolar Soft Part Sarcoma
  • +18 more
  • Portland, Oregon
  • +1 more
Sep 23, 2021

Malignant Tumor, Nausea, Vomiting Trial in Houston (Netupitant, Palonosetron, Palonosetron Hydrochloride)

Completed
  • Malignant Neoplasm
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Mar 4, 2022

Myopia Trial in China, India (Single vision spectacle lens, Single vision spectacle lens + S.T.O.P.® Kit 1, Single vision

Not yet recruiting
  • Myopia
  • Single vision spectacle lens
  • +4 more
  • Tianjin, Heping District, China
  • +4 more
Nov 15, 2023

Relapsed or Refractory Multiple Myeloma Trial in United States (CAR2 Anti-CD38 A2 CAR-T Cells)

Completed
  • Relapsed or Refractory Multiple Myeloma
  • CAR2 Anti-CD38 A2 CAR-T Cells
  • Jacksonville, Florida
  • +3 more
Mar 14, 2022

Precursor Cell Lymphoblastic Leukemia-Lymphoma, Philadelphia-Positive Acute Lymphoblastic Leukemia, ALL, Adult Trial in Xi'an

Recruiting
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma
  • +2 more
  • Xi'an, Shaanxi, China
    First Affiliated Hospital of Xian Jiaotong University
Sep 29, 2021

Stem Cells in NF1 Tumors of the Central Nervous System

Suspended
  • Neurofibromatosis Type 1
  • Tumors of the Central Nervous System
  • Collection of Stem Cells
  • Washington, District of Columbia
    Children's National Medical Center
Mar 8, 2022

Colorectal Cancer Survivor, Rehabilitation, Quality of Life Trial (multidimensional rehabilitation)

Not yet recruiting
  • Colorectal Cancer Survivor
  • +2 more
  • multidimensional rehabilitation
  • (no location specified)
Jul 21, 2023

Hypophosphatasia Trial in Durham

Recruiting
  • Hypophosphatasia
    • Durham, North Carolina
      Duke University Medical Center
    Jan 27, 2022

    Advanced Hepatocellular Carcinoma Trial in Guangzhou (Bifidobacterium Bifidum Oral Product)

    Recruiting
    • Advanced Hepatocellular Carcinoma
    • Bifidobacterium Bifidum Oral Product
    • Guangzhou, Guangdong, China
      The Third Affiliated Hospital of Sun Yat-Sen University
    Nov 16, 2022

    Solid Tumour Trial in United States (Capivasertib, Midazolam)

    Recruiting
    • Solid Tumour
    • West Hollywood, California
    • +9 more
    Aug 22, 2022

    Prostate Cancer Trial in United States (ARN-509 (Phase 1), ARN-509 (Phase 2))

    Active, not recruiting
    Has Results
    • Prostate Cancer
    • ARN-509 (Phase 1)
    • ARN-509 (Phase 2)
    • San Diego, California
    • +14 more
    Jan 17, 2023

    Neurofibromatosis Type 1, Recurrent Childhood Brain Stem Glioma, Recurrent Childhood Visual Pathway Glioma Trial in United

    Completed
    • Neurofibromatosis Type 1
    • +4 more
    • Laboratory Biomarker Analysis
    • +2 more
    • Los Angeles, California
    • +11 more
    Apr 22, 2022

    Early Diagnosis of Type 1 Diabetes

    Recruiting
    • Type 1 Diabetes
      • Orlando, Florida
        AdventHealth Translational Research Institute
      Feb 15, 2022

      The Water Drinking Test in Glaucoma Study

      Recruiting
      • Glaucoma
      • Modified Diurnal Tension Curve
      • London, United Kingdom
        Imperial College Ophthalmic Research Group
      Mar 7, 2022

      Liver and Intrahepatic Bile Duct Carcinoma, Stage III Intrahepatic Cholangiocarcinoma AJCC v8, Stage IIIA Intrahepatic

      Recruiting
      • Liver and Intrahepatic Bile Duct Carcinoma
      • +5 more
      • Portland, Oregon
        OHSU Knight Cancer Institute
      Oct 11, 2022

      Cardiovascular Disease, Hypertension, Hyperlipidemia Trial in United States (FDA approved drugs to treat blood pressure and

      Completed
      Has Results
      • Cardiovascular Disease
      • +4 more
      • FDA approved drugs to treat blood pressure and cholesterol
      • Chinle, Arizona
      • +3 more
      Jun 15, 2021

      Metastatic Malignant Tumor in the Adult Brain, Primary Brain Tumor Trial in Duarte (procedure, drug, other)

      Active, not recruiting
      • Metastatic Malignant Neoplasm in the Adult Brain
      • Primary Brain Tumor
      • Therapeutic Conventional Surgery
      • +4 more
      • Duarte, California
        City of Hope Medical Center
      Mar 16, 2022

      Secondary Angiosarcoma, Locally Advanced Sarcoma, Metastasis Trial in Nijmegen (Cemiplimab)

      Recruiting
      • Secondary Angiosarcoma
      • +2 more
      • Nijmegen, Netherlands
        RadboudUMC
      Jan 19, 2022

      Shear-wave Elastography Diffuse Liver Disease

      Not yet recruiting
      • Chronic Hepatic
      • Chronic Liver Disease and Cirrhosis
      • Shearwave elastography
      • (no location specified)
      Dec 17, 2021

      Luminal Metastatic breAst caNcer in Real-life Clinical pracTice

      Completed
      • HR+/HER2- Breast Cancer
      • +2 more
      • Moscow, Russian Federation
        Russian Society of Clinical Oncology
      Mar 29, 2023

      Esophageal Squamous Cell Carcinoma Trial in Tianjin (biological, drug, radiation)

      Recruiting
      • Esophageal Squamous Cell Carcinoma
      • Pembrolizumab
      • +3 more
      • Tianjin, Tianjin, China
        Department of minimally invasive esophageal surgery, Tianjin Med
      May 26, 2022

      Squamous Cell Carcinoma of the Head and Neck Trial in United States (SNS-301, Pembrolizumab)

      Terminated
      Has Results
      • Squamous Cell Carcinoma of the Head and Neck
      • San Francisco, California
      • +9 more
      Dec 6, 2022